N-(2-氨基乙基)吗啉，CAS 登记号 2038-03-1，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 N-(2-氨基乙基)吗啉 的 CAS 号：2038-03-1，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
N-(2-Aminoethyl)morpholine · CAS 2038-03-1 · C6H14N2O. UNII T92F2H779P.
| CAS Registry Number | 2038-03-1 |
|---|---|
| PubChem CID | 408285 |
| Molecular formula | C6H14N2O |
| IUPAC name | 2-morpholin-4-ylethanamine |
| UNII (FDA) | T92F2H779P |
| Molecular Weight | 130.19 |
|---|---|
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 130.110613074 |
| Monoisotopic Mass | 130.110613074 |
| Topological Polar Surface Area | 38.5 |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (98.3%), H311 (33.3%), H314 (100%), H317 (80%), H318 (13.3%) |
|---|
H302 (98.3%): Harmful if swallowed [Warning Acute toxicity, oral]
H311 (33.3%): Toxic in contact with skin [Danger Acute toxicity, dermal]
4-(2-Aminoethyl)morpholine; 2038-03-1; 4-Morpholineethanamine; 2-Morpholinoethylamine; N-Aminoethylmorpholine; 2-(Morpholin-4-Yl)Ethan-1-Amine; N-2-Aminoethylmorpholine; 2-(4-Morpholinyl)ethanamine; beta-Aminoaethyl-morpholin; beta-Aminoaethyl-morpholin [German]; DTXSID4044408; N-(Aminoethyl)morpholine; BRN 0104378; T92F2H779P; 2-morpholino-1-ethanamine; AI3-52273
CAS 2038-03-1; molecular formula C6H14N2O; molecular weight — g/mol.
4-(2-Aminoethyl)morpholine, 2038-03-1, 4-Morpholineethanamine, 2-Morpholinoethylamine, N-Aminoethylmorpholine, 2-(Morpholin-4-Yl)Ethan-1-Amine.
Hazard statements reported: H302, H311, H314, H317, H318.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.